More See Measles as Dangerous than COVID-19, Over One in Five (23%) Canadians Afraid to Talk About Vaccines with Friends and Family

Three in four Canadians see measles as dangerous, while fewer say the same about COVID-19 or the flu.

Even though those with  kids in the household are less likely to think the COVID-19 vaccine is safe (58%) compared to those without (75%), both those with kids  (80%) and without (85%) agree the measles vaccine is safe.

The majority of Canadians agree that the anti-vaccine movement will be responsible for many people getting sick, but just over quarter think humans don’t need vaccines to build immunity. Men (32%) are more likely to think this than women (23%). Canadians aged 18-34 (29%) and 35-54 (26%) are more afraid to talk about vaccines with friends and family than those aged 55+ (17%).

These are some of the findings of an Ipsos poll conducted between March 15 and 18, 2024, on behalf of Global News. For this survey, a sample of 1,000 Canadians aged 18+ was interviewed. Quotas and weighting were employed to ensure that the sample’s composition reflects that of the Canadian population according to census parameters. The precision of Ipsos online polls is measured using a credibility interval. In this case, the poll is accurate to within ± 3.5 percentage points, 19 times out of 20, had all Canadians aged 18+ been polled. The credibility interval will be wider among subsets of the population. All sample surveys and polls may be subject to other sources of error, including, but not limited to coverage error, and measurement error.

For more information on this news release, please contact:
Sean Simpson
Senior Vice President, Ipsos Public Affairs Canada 
+1 416 324 2002
[email protected]

Ipsos is one of the largest market research and polling companies globally, operating in 90 markets and employing nearly 20,000 people. 
Our passionately curious research professionals, analysts and scientists have built unique multi-specialist capabilities that provide true understanding and powerful insights into the actions, opinions and motivations of citizens, consumers, patients, customers or employees. Our 75 business solutions are based on primary data from our surveys, social media monitoring, and qualitative or observational techniques. 
“Game Changers” – our tagline – summarizes our ambition to help our 5,000 clients navigate with confidence our rapidly changing world. 
Founded in France in 1975, Ipsos has been listed on the Euronext Paris since July 1, 1999. The company is part of the SBF 120, Mid-60 indices, STOXX Europe 600 and is eligible for the Deferred Settlement Service (SRD).
ISIN code FR0000073298, Reuters ISOS.PA, Bloomberg IPS:FP 
http://www.ipsos.com/